The 2010 outbreak of poliomyelitis in Tajikistan: Epidemiology and lessons learnt

Eurosurveillance

Volumn 19, Issue 7, 2014, Pages

  Yakovenko, M L ^a,b   Gmyl, A P ^a,b   Ivanova, O E ^e   Eremeeva, T P ^a   Ivanov, A P ^a   Prostova, M A ^a   Baykova, O Y ^a   Isaeva, O V ^a   Lipskaya, G Y ^b   Shakaryan, A K ^a   Kew, O M ^c   Deshpande, J M ^d   Agol, V I ^a,b  

^a CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^e Indian Council of Medical Research ^*

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN VP1;

ADOLESCENT; ARTICLE; CHILD; COMPARATIVE MOLECULAR FIELD ANALYSIS; COXSACKIE VIRUS B; ECHO VIRUS; ENTEROVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FECES ANALYSIS; FLACCID PARALYSIS; GENE SEQUENCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLIOMYELITIS; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SERODIAGNOSIS; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 84894280788     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.7.20706     Document Type: Article

References (41)

1. Forty-first World Health Assembly. Global eradication of poliomyelitis by the year 2000. Resolution WHA 41.28. Geneva: World Health Organization; 1988. Available from: http://www.polioeradication.org/content/publications/19880513_resolution.pdf
2. Global Polio Eradication Initiative. Wild Poliovirus 2009 - 2014. Geneva: World Health Organization; 2014. Available from: http://www.polioeradication.org/Portals/0/Document/Data&Monitoring/Wild_poliovirus_list_2008_2014_11Feb.pdf
3. Agol VI.Vaccine-derived polioviruses. Biologicals. 2006;34(2):103-108. http://dx.doi.org/10.1016/j.biologicals.2006.02.007
4. Centers for Disease Control and Prevention. Outbreaks following wild poliovirus importations - Europe, Africa, and Asia, January 2009 - September 2010. MMWR Morb Mortal Wkly Rep. 2010;59(43):1393-1399.
5. World Health Organization Regional Office for Europe (WHO/Europe). Report of the 24th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication. Copenhagen: WHO/Europe; 2011. Available from: http://www.euro.who.int/__data/assets/pdf_file/0018/145314/e95119.pdf
6. World Health Organization (WHO). Manual for the virological investigation of poliomyelitis. 4th ed. WHO/IVB/04.10. Geneva: WHO; 2004. Available from: http://whqlibdoc.who.int/hq/2004/WHO_IVB_04.10.pdf
7. van der Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, Crainic R, et al. A comparative study of five methods of intratypic differentiation of polioviruses. J ClinMicrobiol. 1995;33(10):2562-2566.
8. Kilpatrick DR, Yang CF, Ching K, Vincent A, Iber J, Campagnoli R, et al. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol. 2009;47(6):1939-1941. http://dx.doi.org/10.1128/JCM.00702-09
9. Kilpatrick DR, Iber JC, Chen Q, Ching K, Yang SJ, De L, et al. Poliovirus serotype-specific VP1 sequencing primers. J Virol Methods. 2011;174(1-2):128-130. http://dx.doi.org/10.1016/j.jviromet.2011.03.020
10. World Health Organization (WHO). Manual for the virological investigation of polio. WHO/EPI/GEN/97.1.1. Geneva: WHO; 1997. Available from: http://whqlibdoc.who.int/hq/1997/WHO_EPI_GEN_97.01.pdf
11. Dragunsky EM, Ivanov AP, Wells VR, Ivshina AV, Rezapkin GV, Abe S, et al. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccine: a new surrogate method for predicting vaccine efficacy. J Infect Dis. 2004;190(8):1404-1412. http://dx.doi.org/10.1086/424524
12. Yakovenko ML, Cherkasova EA, Rezapkin GV, Ivanova OE, Ivanov AP, Eremeeva TP, et al. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J Virol. 2006;80(6):2641-2653. http://dx.doi.org/10.1128/JVI.80.6.2641-2653.2006
13. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 2012;29(8):1969-1973. http://dx.doi.org/10.1093/molbev/mss075
14. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73(1):152-160.
15. Gavrilin GV, Cherkasova EA, Lipskaya GY, Kew OM, Agol VI. Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol. 2000;74(16):7381-7390. http://dx.doi.org/10.1128/JVI.74.16.7381-7390.2000
16. Jorba J, Campagnoli R, De L, Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol. 2008;82(9):4429-4440. http://dx.doi.org/10.1128/JVI.02354-07
17. Lipskaya GY, Chervonskaya EA, Belova GI, Maslova SV, Kutateladze TN, Drozdov SG, et al. Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. J Gen Virol. 1995;76(Pt 7):1687-1699. http://dx.doi.org/10.1099/0022-1317-76-7-1687
18. World Health Organization Regional Office for the Western Pacific. Wild poliovirus in China. WHO/Western Pacific. [Accessed: 18 February 2014]. Available from: http://www.wpro.who.int/immunization/news/wild_poliovirus_China/en/index.html
19. Chiba Y, Murakami H, Kobayashi M, Shimizu H, Yoshida H, Yoneyama T, et al. A case of poliomyelitis associated with infection of wild poliovirus in Qinghai Province, China, in October 1999. Jpn J Infect Dis. 2000;53(3):135-6.
20. Global Polio Eradication Initiative. Surveillance. Geneva. World Health Organization. [Accessed: 18 February 2014]. Available from: http://www.polioeradication.org/Dataandmonitoring/Surveillance.aspx
21. Shyshov AS, Saifullin MA, Shakaryan AK, Ivanova OE, Sachkova IY. A case of poliovirus infection caused by a wild strain in the adult patient. Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(10 Pt 1):77-80. Russian.
22. Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172(11):1213-1229. http://dx.doi.org/10.1093/aje/kwq320
23. Khetsuriani N, Pallansch MA, Jabirov S, Saparova N, Oberste MS, Wannemuehler K, et al. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010. Vaccine. 2013;31(42)4911-4916. http://dx.doi.org/10.1016/j.vaccine.2013.06.106
24. Grassly NC, Fraser C, Wenger J, Deshpande JM, Sutter RW, Heymann DL, et al. New strategies for the elimination of polio from India. Science. 2006;314(5802):1150-3. http://dx.doi.org/10.1126/science.1130388
25. World Health Organization; United Nations Children's Fund. Countries and territories, Tajikistan. In: Immunization summary. A statistical reference containing data through 2012, WHO/UNICEF; 2014. p 171. Available from: http://www.childinfo.org/files/immunization_summary_2012_en.pdf
26. World Health Organization (WHO). WHO-UNICEF estimates of Pol3 coverage. Geneva: WHO. [Accessed:18 February 2014]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragepol3.html
27. Grassly NC, Jafari H, Bahl S, Durrani S, Wenger J, Sutter RW, et al. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J Infect Dis. 2010;201(10):1535-1543.http://dx.doi.org/10.1086/651952
28. Ogra PL, Okayasu H, Czerkinsky C, Sutter RW. Mucosal immunity to poliovirus. Expert Rev Vaccines. 2011;10(10):1389-1392. http://dx.doi.org/10.1586/erv.11.106
29. Dahourou G, Guillot S, Le Gall O, Crainic R. Genetic recombination in wild-type poliovirus. J Gen Virol. 2002;83(Pt 12):3103-3110.
30. Liu HM, Zheng DP, Zhang LB, Oberste MS, Kew OM, Pallansch MA. Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol. 2003;77(20):10994-101005. http://dx.doi.org/10.1128/JVI.77.20.10994-11005.2003
31. Rakoto-Andrianarivelo M, Guillot S, Iber J, Balanant J, Blondel B, Riquet F, et al. Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar. PLoS Pathog. 2007;3(12):e191. http://dx.doi.org/10.1371/journal.ppat.0030191
32. Ehrenfeld E, Brown D, Jia XY, Summers DF. Antibodies against viral nonstructural proteins in response to infection with poliovirus. J Infect Dis. 1995;171(4):845-850. http://dx.doi.org/10.1093/infdis/171.4.845
33. Cedillo-Barrón L, Foster-Cuevas M, Belsham GJ, Lefèvre F, Parkhouse RM. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol. 2001;82(Pt 7):1713-1724.
34. García-Briones MM, Blanco E, Chiva C, Andreu D, Ley V, Sobrino F. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology. 2004;322(2):264-275. http://dx.doi.org/10.1016/j.virol.2004.01.027
35. Jia XY, Summers DF, Ehrenfeld E. Host antibody response to viral structural and nonstructural proteins after hepatitis A virus infection. J Infect Dis. 1992;165(2):273-280. http://dx.doi.org/10.1093/infdis/165.2.273
36. Jin Y-H, Kang B, Kim BS. Theiler's Virus Infection Induces a Predominant Pathogenic CD4+ T Cell Response to RNA Polymerase in Susceptible SJL/J Mice. J Virol. 2009;83(21):10981-10992. http://dx.doi.org/10.1128/JVI.01398-09
37. Kerkvliet J, Edukulla R, Rodriguez M. Novel roles of the picornaviral 3D polymerase in viral pathogenesis. AdvVirol. 2010;2010:368068.
38. Patel MK, Konde MK, Didi-Ngossaki BH, Ndinga E, Yogolelo R, Salla M, et al. An outbreak of wild poliovirus in the Republic of Congo, 2010-2011.Clin Infect Dis. 2012;55(10):1291-1298. http://dx.doi.org/10.1093/cid/cis714
39. Chumakov K, Ehrenfeld E, Wimmer E, Agol VI. Vaccination against polio should not be stopped. Nature Rev Microbiol. 2007;5(12):952-958. http://dx.doi.org/10.1038/nrmicro1769
40. Global Polio Eradication Initiative. Polio eradication and endgame strategic plan 2013-2018. Geneva: World Health Organization; 2013. p 51-64. Available from: http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/PEESP_EN_US.pdf
41. Anis E, Kopel E, Singer S, Kaliner E, Moerman L, Moran-Gilad J, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill. 2013;18(38). pii: 20586